Book contents
- Frontmatter
- Contents
- Contributors
- Preface
- 1 Introduction: gene therapy approaches to cancer
- 2 Principles of transformation-directed cancer therapy
- 3 Vectors for cancer gene therapy
- 4 Genetically engineering drug sensitivity and drug resistance for the treatment of cancer
- 5 Oncogene inactivation and replacement strategies for cancer
- 6 Genetically modified tumor cells as tumor vaccines
- 7 Genetically modified lymphocytes and hematopoietic stem cells as therapeutic vehicles
- 8 Pharmacologic effects of oligonucleotides and some clinical applications
- 9 Current status of gene marking and gene therapy in oncology clinical trials
- 10 Safety testing for gene therapy products
- Index
Contributors
Published online by Cambridge University Press: 01 April 2010
- Frontmatter
- Contents
- Contributors
- Preface
- 1 Introduction: gene therapy approaches to cancer
- 2 Principles of transformation-directed cancer therapy
- 3 Vectors for cancer gene therapy
- 4 Genetically engineering drug sensitivity and drug resistance for the treatment of cancer
- 5 Oncogene inactivation and replacement strategies for cancer
- 6 Genetically modified tumor cells as tumor vaccines
- 7 Genetically modified lymphocytes and hematopoietic stem cells as therapeutic vehicles
- 8 Pharmacologic effects of oligonucleotides and some clinical applications
- 9 Current status of gene marking and gene therapy in oncology clinical trials
- 10 Safety testing for gene therapy products
- Index
Summary

- Type
- Chapter
- Information
- Gene Therapy in the Treatment of CancerProgress and Prospects, pp. ix - xPublisher: Cambridge University PressPrint publication year: 1998